Nexium (Esomeprazole Magnesium)

Nexium, a proton pump inhibitor, acts on the gastric acid secretion pathway to manage acid‑related disorders.

• Gastro‑oesophageal reflux disease (GERD): relief of heartburn and promotion of esophageal healing.
• Erosive esophagitis: reduction of mucosal damage and acceleration of ulcer resolution.
• Helicobacter pylori eradication regimen: enhances the effectiveness of antibiotic combinations by suppressing gastric acid.
• Zollinger‑Ellison syndrome: control of excessive gastric acid production associated with gastrin‑secreting tumors.

• Esomeprazole magnesium selectively binds to and inhibits the H+/K+ ATPase enzyme (the proton pump) located on the secretory surface of gastric parietal cells. This irreversible inhibition blocks the final step of acid production, leading to a sustained decrease in gastric acidity and allowing healing of acid‑related mucosal injury.

Common Side Effects

• Headache: mild to moderate pain often reported during early therapy.
• Diarrhea: loose stools that may resolve with continued use.
• Nausea: transient feeling of queasiness.
• Abdominal pain: discomfort in the stomach region.
• Flatulence: increased intestinal gas.
• Constipation: reduced bowel movements.

Serious or Rare Side Effects

• Severe allergic reactions: rash, swelling, or anaphylaxis requiring immediate medical attention.
• Clostridioides difficile infection: severe colitis presenting with watery diarrhea.
• Low serum magnesium: may cause muscle cramps, weakness, or cardiac arrhythmias.
• Bone fractures: increased risk with long‑term use due to altered calcium absorption.
• Stevens‑Johnson syndrome: rare skin blistering disorder.
• Hepatic injury: elevated liver enzymes or jaundice.

Before initiating therapy, consider the following precautions:

• Assess renal function: dose adjustment may be required in severe renal impairment.
• Monitor for infection: prolonged use can increase risk of gastrointestinal infections.
• Review concomitant medications: drugs that need gastric acidity for absorption may have reduced efficacy.
• Evaluate bone health: long‑term therapy may affect calcium absorption and increase fracture risk.
• Store at room temperature: keep in the original container, protect from moisture and light.

Nexium may interact with several medicines; awareness of the interaction level helps guide management.

Major Interactions (Avoid)

• Clopidogrel: reduced antiplatelet effect, increasing cardiovascular risk.
• Atazanavir: decreased absorption of atazanavir, compromising HIV therapy.
• High‑dose methotrexate: increased toxicity due to reduced renal clearance.
• Warfarin: potential increase in INR, enhancing bleeding risk.

Moderate Interactions (Monitor Closely)

• Digoxin: elevated serum levels may require dose adjustment.
• Diazepam: increased sedation due to higher plasma concentrations.
• Phenytoin: reduced phenytoin levels may diminish seizure control.